Client Result

Diagnostic Advisory Board

Project Overview

A diagnostics company requested DeciBio to help an advisory board (ad board) to understand how to position its relatively new somatic oncology genomics profiling product in an already competitive market

DeciBio Approach

DeciBio recruited and coordinated the scheduling for 8 oncology KOLs (both oncologists and pathologists) for a 3-hour virtual ad board. With input from the client, DeciBio prepared the questionnaire and stimuli for the attendees and facilitated the discussion.

At a glance
8
Advisory Board Attendees
3
Duration of the ad board (hours)
Outcomes

DeciBio delivered a recording and written summary of the ad board discussion. The summary included key takeaways related to:

  • Current use of genomic profiling assays in routine care
  • Factors that drive test differentiation
  • Evolution of current offering and potential future offerings
  • Tradeoffs and differentiating features of various evolutions
  • Competitor feedback and drivers of switching
  • Perceived value of potential new features and ancillary offerings
Timeline

Geographic Scope

U.S.

Industry

Clinical Diagnostics

capabilities

Advisory Board

Voice-Of-Customer Research

KOL Identification

Related Client Results
Clinical Diagnostics
Genetic Testing Lab Target Assessment
A large pharmaceutical company asked DeciBio to help it identify and evaluate clinical genetic testing labs for potential partnership or acquisition
Target Identification
Clinical Diagnostics
MRD Monitoring Market Assessment and Strategy
A diagnostics player wanted to determine which indications and use cases to target and develop a product road map for its planned MRD offering
Biomarker and Diagnostic Strategy
Go-to-Market Strategy
Clinical Diagnostics
Early Cancer Detection Competitor Landscape Monitoring
A top diagnostics player wanted to monitor the commercial, clinical, research, and corporate activities in the public domain for three of the key players in the cancer early detection market.
Competitive Analysis
Clinical Diagnostics
IVDR Diagnostics Strategy
A top-10 diagnostics company wanted to gauge laboratory preparedness and reactions to the impending implementation of IVDR, and how that would impact portfolio strategy
Voice-Of-Customer Research
Biomarker and Diagnostic Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Precision Medicine. Precision Insights.
© DeciBio 2022. All rights reserved.
Privacy | Terms & Conditions